Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

por Drevets, Wayne C., Price, Joseph L., Furey, Maura L.
Publicado 2008

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine

por Furey, Maura L., Drevets, Wayne C., Szczepanik, Joanna, Khanna, Ashish, Nugent, Allison, Zarate, Carlos A.
Publicado 2015

The Extended Functional Neuroanatomy of Emotional Processing Biases for Masked Faces in Major Depressive Disorder

por Victor, Teresa A., Furey, Maura L., Fromm, Stephen J., Bellgowan, Patrick S. F., Öhman, Arne, Drevets, Wayne C.
Publicado 2012

Neural Correlates of Suicidal Ideation and Its Reduction in Depression

por Ballard, Elizabeth D., Lally, Níall, Nugent, Allison C., Furey, Maura L., Luckenbaugh, David A., Zarate, Carlos A.
Publicado 2015

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

por Reed, Jessica L., Nugent, Allison C., Furey, Maura L., Szczepanik, Joanna E., Evans, Jennifer W., Zarate, Carlos A.
Publicado 2018

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

por Park, Lawrence, Furey, Maura, Nugent, Allison C, Farmer, Cristan, Ellis, Jessica, Szczepanik, Joanna, Lener, Marc S, Zarate, Carlos A
Publicado 2018

Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

por Saad, Ziad, Hibar, Derrek, Fedgchin, Maggie, Popova, Vanina, Furey, Maura L, Singh, Jaskaran B, Kolb, Hartmuth, Drevets, Wayne C, Chen, Guang
Publicado 2020

Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time

por Triana-Baltzer, Gallen, Timmers, Maarten, De Boer, Peter, Schoene, Manja, Furey, Maura, Bleys, Cathy, Vrancken, Isabeau, Slemmon, Randy, Ceusters, Marc, van Nueten, Luc, Kolb, Hartmuth
Publicado 2022

Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder

por Niciu, Mark J., Luckenbaugh, David A., Ionescu, Dawn F., Richards, Erica M., Vande Voort, Jennifer L., Ballard, Elizabeth D., Brutsche, Nancy E., Furey, Maura L., Zarate, Carlos A.
Publicado 2014

Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression

por Chen, Guang, Chen, Li, Zhang, Yun, Li, Xiang, Lane, Rosanne, Lim, Pilar, Daly, Ella J, Furey, Maura L, Fedgchin, Maggie, Popova, Vanina, Singh, Jaskaran B, Drevets, Wayne C
Publicado 2022

Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression

por Guo, Wei, Machado-Vieira, Rodrigo, Mathew, Sanjay, Murrough, James W., Charney, Dennis S., Grunebaum, Matthew, Oquendo, Maria A., Kadriu, Bashkim, Akula, Nirmala, Henter, Ioline, Yuan, Peixiong, Merikangas, Kathleen, Drevets, Wayne, Furey, Maura, Mann, J. John, McMahon, Francis J., Zarate Jr., Carlos A., Shugart, Yin Yao
Publicado 2018

Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression

por Guo, Wei, Machado-Vieira, Rodrigo, Mathew, Sanjay, Murrough, James W., Charney, Dennis S., Grunebaum, Matthew, Oquendo, Maria A., Kadriu, Bashkim, Akula, Nirmala, Henter, Ioline, Yuan, Peixiong, Merikangas, Kathleen, Drevets, Wayne, Furey, Maura, Mann, J. John, McMahon, Francis J., Zarate, Carlos A., Shugart, Yin Yao
Publicado 2019